POLIOVIRUS — COMPLETE MICROBIOLOGY + CLINICAL + PUBLIC-HEALTH REVIEW

Dr Harish M Nair
Aug 12
18 min read

1. Basic classification

Characteristic	Poliovirus
Family	Picornaviridae
Genus	Enterovirus
Species	Enterovirus C
Genome	ssRNA, positive sense
Envelope	Absent
Capsid	Icosahedral
Genome size	~7.4 kb
Replication	Cytoplasm
Replication strategy	Positive-sense RNA directly functions as mRNA
Major receptor	CD155/PVR — poliovirus receptor
Serotypes	PV1, PV2, PV3
Natural host	Humans
Major transmission	Feco-oral
Main site of multiplication	Oropharynx + intestine
Major target in paralytic disease	Motor neurons
Major reservoir	Humans

Poliovirus is a small, non-enveloped, positive-sense RNA enterovirus. The three serotypes are antigenically distinct, with little clinically meaningful cross-protection between them. (CDC)

Important taxonomy point

Older textbooks commonly present:

Family → Picornaviridae → Genus Enterovirus → Poliovirus

Modern ICTV terminology places polioviruses within Enterovirus C. For examination purposes, it is useful to know both the traditional and current terminology.

2. Historical importance

Poliomyelitis has been recognized for centuries, but modern understanding developed during the 19th and 20th centuries.

Important milestones:

1789 — Michael Underwood described characteristic lower-limb weakness.
1908 — Landsteiner and Popper demonstrated an infectious agent in poliomyelitis.
1949 — Enders, Weller and Robbins demonstrated propagation of poliovirus in tissue culture.
1952 — major U.S. epidemic.
1955 — Salk inactivated poliovirus vaccine introduced.
1961–1963 — Sabin oral poliovirus vaccines introduced progressively.
1988 — Global Polio Eradication Initiative launched.
2014 — WHO South-East Asia Region certified polio-free.
2015 — wild poliovirus type 2 declared eradicated.
2019 — wild poliovirus type 3 declared eradicated.
2020 — WHO African Region certified free of wild poliovirus.
2021 onward — novel OPV2 increasingly used for cVDPV2 outbreaks.

India's last indigenous wild-poliovirus case occurred in January 2011, and the WHO South-East Asia Region was certified polio-free in March 2014. (World Health Organization)

3. Morphology

Poliovirus is a typical picornavirus.

Virion

Diameter approximately 27–30 nm
Non-enveloped
Icosahedral symmetry
Compact capsid
No matrix
No envelope-associated proteins

The mature virion contains four structural proteins:

VP1 + VP2 + VP3 + VP4

Capsid organization

The outer surface is formed principally by:

VP4 is located internally and is associated with the inner surface of the capsid.

Why is this important?

The exposed capsid proteins contain the major neutralizing antigenic sites.

Especially important:

VP1 → major antigenic/neutralizing determinants

This is one reason VP1 sequencing is extremely important in modern poliovirus epidemiology.

4. Physicochemical properties

Poliovirus is:

Resistant to

Acidic pH
Ether
Chloroform
Many lipid solvents

because it is non-enveloped.

Relatively sensitive to

Heat
Formaldehyde under appropriate conditions
Chlorine/disinfectants under appropriate conditions

The environmental stability of enteroviruses contributes significantly to their fecal-oral transmission.

Exam pearl

Non-enveloped + acid stable → survives passage through the stomach → intestinal replication.

5. Genome

This is particularly important for a microbiologist.

Poliovirus has:

Positive-sense single-stranded RNA

approximately 7.4 kb.

The genome has:

5′ VPg ─ 5′UTR ─ P1 ─ P2 ─ P3 ─ 3′UTR ─ poly(A) 3′

5′ end

The genome is covalently linked to:

VPg = viral protein genome-linked

rather than the conventional 5′ methylated cap found in cellular mRNA.

5′ UTR

Contains:

Cloverleaf structure
Internal ribosome entry site (IRES)
Cis-acting replication elements

The IRES permits cap-independent translation. (PubMed Central (PMC))

6. Genome organization

The single ORF is divided functionally into:

P1

Codes for structural proteins:

VP4 → VP2 → VP3 → VP1

P2

Contains nonstructural proteins involved in:

Host-virus interaction
Membrane rearrangement
Replication
Host translation shutoff

Important proteins include:

P3

Contains major replication machinery:

3A
3B = VPg
3C protease
3D polymerase

The genome therefore essentially follows:

P1 = capsid

P2 + P3 = replication/nonstructural machinery

(PubMed Central (PMC))

7. Viral proteins — high-yield microbiology

Protein	Major function
VP1	Surface capsid protein; receptor interaction/major antigenic determinants
VP2	Capsid
VP3	Capsid
VP4	Internal capsid protein; involved in uncoating
2A	Protease; contributes to host translation shutoff
2B	Membrane-associated protein
2C	ATPase/helicase-related replication functions
3A	Membrane-associated replication functions
3B/VPg	Genome-linked protein; primer for RNA synthesis
3C	Protease
3Dpol	RNA-dependent RNA polymerase

8. Receptor

The major cellular receptor is:

CD155 / PVR

Poliovirus receptor = CD155

It belongs to the immunoglobulin superfamily.

CD155 is important for:

Attachment
Entry
Tissue tropism
Neurotropism

Laboratory cell lines expressing the human poliovirus receptor, including L20B cells, are useful in poliovirus isolation systems. (CDC)

Very important conceptual point

The distribution of CD155 alone does not completely explain neurotropism.

Neurovirulence depends on multiple viral and host determinants, including:

receptor interactions
intracellular replication efficiency
tissue-specific factors
innate immune responses
viral genetic determinants

9. Replication cycle

This is an important postgraduate microbiology topic.

Step 1 — Attachment

Virus binds:

CD155/PVR

on susceptible cells.

Step 2 — Entry

The virus enters the cell through receptor-mediated mechanisms.

Capsid conformational changes facilitate genome release.

Step 3 — Uncoating

The RNA genome is released into the cytoplasm.

Because it is positive-sense RNA:

The genome itself acts as mRNA.

10. Translation

Unlike cellular mRNA, poliovirus RNA does not require a conventional 5′ cap.

Translation occurs through:

Internal Ribosome Entry Site — IRES

The viral RNA recruits ribosomes using the IRES.

One large polyprotein is produced.

RNA
 ↓
Polyprotein
 ↓
Proteolytic cleavage
 ↓
Structural + nonstructural proteins

Viral proteases including 2A and 3C/3CD process the polyprotein. (PubMed Central (PMC))

11. Host translation shutoff

One of the elegant mechanisms of poliovirus.

2A protease

Cleaves:

eIF4G

This inhibits normal host cap-dependent translation.

Result:

Host protein synthesis ↓

while

IRES-dependent viral translation continues.

Exam question

How does poliovirus preferentially translate its own RNA?

Answer: IRES-mediated cap-independent translation + inhibition of host cap-dependent translation by viral protease.

12. RNA replication

The viral RNA-dependent RNA polymerase is:

3Dpol

Replication occurs in the cytoplasm on virus-induced membrane structures.

VPg

VPg acts as a protein primer.

It becomes uridylylated:

VPg → VPg-pUpU

and initiates RNA synthesis.

The viral replication cycle involves:

(+)-RNA
   ↓
(-)-RNA intermediate
   ↓
multiple (+)-RNA genomes
   ↓
translation / encapsidation

The 3′ poly(A) region and several cis-acting replication elements participate in replication. (PubMed Central (PMC))

13. Assembly

Structural proteins form the capsid.

Genomic RNA is packaged into the newly formed virion.

Maturation involves cleavage of capsid precursors and conversion into the mature infectious virion.

14. Release

Poliovirus is classically released primarily through:

cell lysis

rather than budding.

This is consistent with its non-enveloped nature.

15. Cytopathic effect

Poliovirus produces characteristic cytopathic effects in susceptible cell cultures.

Depending on the cell line, one may see:

Cell rounding
Increased refractility
Degeneration
Detachment
Cell death

The virus can be isolated in susceptible cell cultures such as RD and L20B systems used in polio laboratory networks. (CDC)

16. Antigenic properties

There are three serotypes:

Poliovirus type 1

PV1

Poliovirus type 2

PV2

Poliovirus type 3

PV3

They are:

Antigenically distinct.

Therefore:

Immunity to PV1 does not provide reliable protection against PV2/PV3.

Neutralizing antibodies are predominantly type-specific. (CDC)

17. Wild poliovirus types

Historically:

WPV1
WPV2
WPV3

Current status:

WPV2

Eradicated

WPV3

Eradicated

WPV1

Still remains the wild poliovirus type of concern globally.

Thus:

Only WPV1 continues to circulate as wild poliovirus.

WHO's current eradication strategy focuses on interrupting WPV1 transmission while simultaneously stopping circulating vaccine-derived poliovirus transmission. (World Health Organization)

18. Genetic variation

This is extremely important for a microbiologist.

Poliovirus is an RNA virus.

Its RNA-dependent RNA polymerase:

3Dpol

has limited proofreading capacity.

Therefore:

high mutation rate → genetic diversity

Additional genetic change occurs through:

Recombination

Polioviruses can recombine with other enteroviruses, particularly within Enterovirus C.

This becomes especially important in the evolution of vaccine-derived strains.

19. Vaccine-derived poliovirus

This is one of the most important modern polio concepts.

Oral polio vaccine contains live attenuated poliovirus.

In populations with inadequate immunity:

OPV administration
       ↓
Replication in intestine
       ↓
Faecal shedding
       ↓
Person-to-person transmission
       ↓
Accumulation of mutations/recombination
       ↓
Loss of attenuation
       ↓
Circulating vaccine-derived poliovirus

A vaccine-derived poliovirus becomes classified as circulating (cVDPV) when it demonstrates sustained community transmission rather than simply being a vaccine virus detected in an individual.

20. VDPV categories

Three major categories:

1. cVDPV

Circulating vaccine-derived poliovirus

Associated with community transmission.

2. iVDPV

Immunodeficiency-associated vaccine-derived poliovirus

Occurs in certain individuals with prolonged infection/shedding, particularly those with primary immunodeficiency.

3. aVDPV

Ambiguous vaccine-derived poliovirus

Doesn't fit clearly into the circulating or immunodeficiency-associated categories.

21. Why did vaccine-derived poliovirus become important?

The central issue is:

OPV → excellent intestinal replication and transmission-blocking immunity

but:

live attenuated virus → possibility of genetic reversion

If population immunity becomes inadequate:

vaccine virus can circulate for prolonged periods → regain neurovirulence → cVDPV outbreaks.

This is why eradication requires eliminating all poliovirus transmission, not merely wild poliovirus.

WHO's current surveillance framework specifically includes AFP surveillance, environmental surveillance, iVDPV surveillance, laboratory/genomic surveillance and centralized information management. (World Health Organization)

22. Transmission

Main route:

Feco-oral

Transmission occurs through:

contaminated hands
contaminated food
contaminated water
sewage
close household/community contact

Respiratory/oral transmission can occur, particularly early in infection.

Virus can be present in nasopharyngeal secretions for approximately 1–2 weeks, while fecal shedding can persist for several weeks. (CDC)

23. Why polio thrives in poor sanitation

Poliovirus has:

high infectivity
environmental stability
fecal-oral transmission
asymptomatic infection
prolonged intestinal shedding
efficient human-to-human transmission

Therefore:

Poor sanitation + low vaccination coverage = ideal conditions for transmission.

24. Pathogenesis — complete sequence

This is the most important clinical-microbiology integration.

Ingestion
   ↓
Oropharyngeal replication
   ↓
Tonsils / lymphoid tissue
   ↓
Intestinal replication
   ↓
Peyer patches / local lymphoid tissue
   ↓
Primary viremia
   ↓
Reticuloendothelial / other tissues
   ↓
Secondary viremia
   ↓
CNS invasion in a small proportion
   ↓
Motor neuron infection
   ↓
Neuronal destruction
   ↓
Acute flaccid paralysis

CDC describes replication in the oropharynx and GI tract, invasion of local lymphoid tissue, bloodstream dissemination and subsequent CNS infection in paralytic disease. (CDC)

25. Why only a minority develop paralysis

This is a classic epidemiological concept.

Most infections are:

asymptomatic

Only a minority progress to CNS disease.

Approximately:

~72% asymptomatic
~24% minor illness
~1–5% nonparalytic aseptic meningitis
<1% paralytic disease

The exact percentages vary somewhat among standard sources and study populations, so they should be treated as approximate rather than absolute.

CDC currently states that fewer than 1% of infected individuals develop weakness or paralysis. (CDC)

26. Factors influencing paralytic disease

Risk is influenced by:

Age
Pregnancy
Physical exertion
Trauma
Intramuscular injections
Tonsillectomy
Viral factors
Host immunity
Genetic susceptibility

Historically, intramuscular injections and strenuous physical activity have been associated with increased risk of paralytic disease.

27. Clinical spectrum

Poliovirus infection produces a spectrum:

1. Inapparent infection

No symptoms.

This is the commonest outcome.

2. Abortive poliomyelitis

Also called:

minor illness

Features:

Fever
Malaise
Headache
Sore throat
Nausea
Vomiting
Abdominal discomfort
Myalgia

Usually self-limited.

3. Non-paralytic poliomyelitis

Aseptic meningitis-like illness.

Features:

Fever
Headache
Neck stiffness
Back pain
Muscle pain
Hyperesthesia
Meningeal irritation

CSF:

lymphocytic pleocytosis
mildly elevated protein
normal glucose

28. Paralytic poliomyelitis

Major forms:

Spinal polio

Most characteristic.

Produces:

Acute flaccid asymmetric paralysis

Features:

Hypotonia
Hyporeflexia/areflexia
Muscle weakness
No sensory loss
Often asymmetric
Proximal muscles may be prominently affected

Bulbar polio

Involves:

medulla
cranial nerve nuclei
respiratory centers

Can cause:

dysphagia
dysarthria
nasal speech
facial weakness
impaired airway protection
respiratory failure

Bulbospinal polio

Combination of:

spinal + bulbar involvement

This is particularly dangerous because of respiratory compromise.

29. Characteristic neurological picture

The classic description:

Acute asymmetric flaccid paralysis with preserved sensation.

This differentiates polio from many spinal cord diseases.

The lesion is primarily:

anterior horn motor neurons

and brainstem motor nuclei.

30. Why paralysis is flaccid

Poliovirus destroys:

lower motor neurons

Therefore:

hypotonia
hyporeflexia
flaccid weakness
muscle atrophy

occur.

This is fundamentally an anterior horn cell disease.

31. Respiratory failure

Death in severe poliomyelitis may result from:

1. Respiratory muscle paralysis

especially:

diaphragm
intercostal muscles

2. Bulbar dysfunction

leading to:

aspiration
airway obstruction
inability to handle secretions

Historically, this produced the dramatic use of the negative-pressure ventilator ("iron lung") during major epidemics.

32. Incubation

Approximately:

Non-paralytic disease

3–6 days

Paralytic disease

Paralysis generally develops approximately:

7–21 days after infection

with variation between individuals. (CDC)

33. Post-polio syndrome

A fascinating late complication.

Occurs years to decades after acute paralytic disease.

Typical interval:

15–40 years

Features:

new muscle weakness
fatigue
muscle pain
joint pain
reduced exercise tolerance
sometimes respiratory or swallowing problems

It is not caused by a new poliovirus infection.

It is thought to reflect long-term stress and degeneration of surviving motor units.

CDC estimates that roughly 25–40% of polio survivors may experience post-polio syndrome, although estimates vary. (CDC)

34. Host immunity

Two major arms are important.

Humoral immunity

Neutralizing antibodies are highly protective against:

viremia
CNS invasion
paralytic disease

Antibodies are largely serotype-specific.

Mucosal immunity

Intestinal IgA and local immunity are particularly important in limiting:

intestinal replication
fecal shedding
transmission

This distinction explains the major immunological difference between:

IPV vs OPV

35. IPV vs OPV — the most important vaccine comparison

Feature	IPV	OPV
Developer	Salk	Sabin
Type	Inactivated	Live attenuated
Route	Injection	Oral
Replication	No	Yes
Systemic immunity	Excellent	Excellent
Intestinal immunity	Less effective	Excellent
Prevention of paralysis	Excellent	Excellent
Prevention of transmission	Less efficient	Excellent
Vaccine virus shedding	No	Yes
VAPP risk	No	Yes, extremely rare
cVDPV risk	No	Yes
Cost/logistics	More difficult	Easy/cheap
Mass campaigns	Less convenient	Highly suitable

CDC notes that OPV strains replicate in intestinal mucosa and lymphoid tissues and may be shed in stool for weeks, with the greatest shedding during the first 1–2 weeks after vaccination. (CDC)

36. IPV

Salk vaccine

Contains:

formalin-inactivated poliovirus

Usually contains antigens from:

Because it is inactivated:

It cannot replicate or revert to neurovirulence.

Advantages:

excellent systemic neutralizing antibody response
prevents paralytic disease
no vaccine-derived poliovirus
no VAPP

Limitation:

less effective than OPV at inducing intestinal mucosal immunity and therefore less effective at stopping intestinal transmission.

37. OPV

Sabin vaccine

Contains live attenuated strains.

Traditional forms:

tOPV

Contains:

PV1 + PV2 + PV3

bOPV

Contains:

PV1 + PV3

After global withdrawal of type-2-containing tOPV in 2016, bOPV became the principal conventional OPV used for type 1/3 protection, while type-2 outbreak response has relied increasingly on monovalent/novel type-2 vaccines. WHO notes the importance of nOPV2 in the current endgame. (World Health Organization)

38. Why OPV is so effective in eradication campaigns

After oral administration:

OPV
 ↓
intestinal replication
 ↓
local IgA
 ↓
reduced wild-virus replication
 ↓
reduced fecal shedding
 ↓
reduced transmission

Additionally, vaccine virus can transiently spread to close contacts and contribute to community immunity.

Therefore:

OPV is exceptionally useful for interrupting transmission.

39. VAPP

Vaccine-associated paralytic poliomyelitis

Rare paralysis associated with live OPV strains.

It can occur in:

vaccine recipients
occasionally close contacts

This is one reason the final eradication phase increasingly emphasizes safer genetically stabilized vaccine approaches and IPV.

40. nOPV2

A major modern development.

Novel oral poliovirus vaccine type 2

Designed to retain the transmission advantages of OPV2 while being more genetically stable and less likely to revert toward neurovirulence.

WHO prequalified an additional nOPV2 formulation in February 2026, strengthening supply for type-2 outbreak response. (World Health Organization)

Important:

nOPV2 is not simply "IPV orally"; it remains a live oral vaccine.

41. Laboratory diagnosis

This is where the microbiologist becomes particularly important.

Specimens

Best specimen:

Stool

Two stool specimens should ideally be collected:

24 hours apart

as early as possible after onset, preferably within approximately 14 days.

CDC identifies stool virus isolation as the most sensitive diagnostic approach and recommends two stool samples 24 hours apart in suspected cases. (CDC)

42. Why stool is better than CSF

Poliovirus replicates extensively in the:

GI tract

and therefore is shed abundantly in stool.

CSF viral detection is uncommon.

Thus:

Negative CSF PCR does NOT exclude poliomyelitis.

This is a very important clinical point.

43. Specimens used

Primary

Stool × 2

Additional

Throat/nasopharyngeal specimen early in illness
CSF — limited sensitivity
Blood — generally poor diagnostic yield

CDC notes that poliovirus may be detected from stool and pharyngeal specimens, whereas isolation from CSF or blood is much less likely. (CDC)

44. Virus isolation

Historically and within the Global Polio Laboratory Network, virus isolation remains fundamental.

Common cell systems include:

RD cells

Rhabdomyosarcoma cell line.

L20B cells

Mouse cells engineered to express:

human poliovirus receptor CD155

This gives them particular value in poliovirus detection.

Other susceptible cell systems include:

HEp-2
HeLa
Vero
MRC-5
monkey kidney-derived cells

CDC lists RD and L20B among susceptible systems used for poliovirus work. (CDC)

45. Identification after isolation

Historically:

cell culture → neutralization / serotyping

Modern laboratory algorithms increasingly rely on:

RT-PCR

followed by:

Intratypic differentiation — ITD

This determines whether the isolate resembles:

wild poliovirus
Sabin vaccine strain
vaccine-derived poliovirus

CDC specifically describes real-time RT-PCR for intratypic differentiation and genome sequencing for genotype/geographic characterization. (CDC)

46. Molecular diagnosis

RT-PCR

Because the genome is RNA:

reverse transcription → PCR

is used.

Modern assays can detect:

poliovirus
serotype
Sabin-like strains
non-Sabin vaccine-derived strains
wild-virus-associated signatures

47. Genome sequencing

This is critical in modern surveillance.

Sequencing is used to:

identify genotype
determine evolutionary relationships
estimate transmission chains
identify geographic origin
distinguish importation from local circulation
characterize vaccine-derived viruses

VP1 sequencing

The VP1 coding region is particularly important for molecular epidemiology.

The virus's evolutionary distance from the corresponding Sabin parental strain is used in defining VDPV categories.

48. Why sequencing is so important

Imagine:

Case A → PV detected
Case B → PV detected
Environmental sewage → PV detected

Culture alone tells you:

"Poliovirus is present."

Sequencing can tell you:

"These viruses belong to the same transmission lineage."

Therefore:

Modern polio microbiology = isolation + molecular characterization + epidemiology.

49. Serology

Serology is less important for routine acute diagnosis than stool virology.

Neutralizing antibodies can support diagnosis in selected circumstances.

Paired sera may demonstrate:

four-fold rise in antibody titre

but this is not the principal modern method for confirming suspected poliomyelitis.

50. CSF findings

In poliomyelitis:

lymphocytic pleocytosis
mildly increased protein
glucose usually normal

But:

CSF poliovirus detection is uncommon.

Therefore CSF is primarily useful for characterizing the neurological syndrome rather than serving as the optimal specimen for viral detection.

51. Differential diagnosis of acute flaccid paralysis

This is crucial for physicians.

Condition	Key clue
Poliomyelitis	Asymmetric AFP, no sensory loss
Guillain-Barré syndrome	Usually symmetric ascending weakness
Transverse myelitis	Sensory level + sphincter involvement
Botulism	Descending paralysis + autonomic symptoms
Diphtheritic neuropathy	Post-diphtheritic neuropathy
Enterovirus-associated AFP	Viral epidemiological context
West Nile neuroinvasive disease	Fever + encephalitis/AFP
Spinal cord compression	Sensory level, sphincter dysfunction
Trauma	Structural history
Acute myelitis	MRI/CSF abnormalities

52. Clinical diagnosis — what should make you think of polio?

Think:

Previously well child + acute fever + rapidly developing asymmetric flaccid limb weakness + decreased reflexes + preserved sensation.

That is a major red flag.

53. AFP surveillance

Polio eradication depends on acute flaccid paralysis surveillance.

Any child under 15 years with:

acute flaccid paralysis

must be investigated according to surveillance protocols.

AFP is not synonymous with polio.

Many other diseases cause AFP.

Therefore:

AFP is a surveillance syndrome, not a diagnosis.

WHO describes nationwide AFP surveillance as the gold-standard clinical surveillance mechanism, supplemented by environmental surveillance. (World Health Organization)

54. Environmental surveillance

This is one of the most fascinating aspects of modern microbiology.

Instead of waiting for a child to become paralysed:

sewage → concentrate → detect poliovirus

This can identify:

asymptomatic circulation
silent transmission
imported virus
vaccine-derived virus

before clinical paralysis becomes apparent.

WHO specifically describes environmental surveillance as a complement to AFP surveillance and notes that it can identify poliovirus in the absence of paralytic cases. (World Health Organization)

55. Why environmental surveillance is extraordinarily valuable

Remember:

Most poliovirus infections are asymptomatic.

Therefore:

Clinical surveillance
       ↓
detects paralysis
       ↓
only a small fraction of infections

Whereas:

Environmental surveillance
       ↓
detects virus shed by infected persons
       ↓
can detect silent transmission

Hence environmental surveillance is an early-warning system.

56. Global Polio Laboratory Network

The Global Polio Laboratory Network (GPLN) provides standardized laboratory support for eradication.

Core functions include:

virus isolation
intratypic differentiation
molecular characterization
sequencing
epidemiological linkage

The current WHO surveillance plan explicitly integrates laboratory testing and genomic sequencing with AFP and environmental surveillance. (World Health

Organization)

57. Biosafety and containment

This is especially relevant to a microbiologist.

As eradication progresses:

poliovirus itself becomes a laboratory biosecurity concern.

Unnecessary infectious poliovirus materials should be destroyed or securely contained in appropriately designated facilities.

WHO's containment framework requires safe handling and storage of retained poliovirus materials in certified Polio Essential Facilities (PEFs). (World Health Organization)

58. Infectious material

Potentially relevant materials include:

live poliovirus isolates
certain infected cell cultures
vaccine seed material
certain clinical samples
environmental samples containing poliovirus
laboratory stocks
some nucleic-acid constructs containing relevant poliovirus sequences

This is why laboratories must follow current national/WHO containment requirements rather than treating poliovirus as an ordinary enterovirus. (CDC)

59. Treatment

There is:

No specific antiviral therapy routinely used to eradicate poliovirus infection.

Treatment is supportive.

Important components

airway management
respiratory support
secretion management
treatment of aspiration
fluid/electrolyte management
pain control
physiotherapy
prevention of contractures
rehabilitation
nutritional support
psychological/social support

60. Management of respiratory failure

Severe bulbar/bulbospinal disease may require:

oxygen
airway protection
non-invasive ventilation in selected patients
invasive mechanical ventilation when required

Historical:

iron lung

Modern:

positive-pressure ventilation

61. Management of post-polio syndrome

There is no curative antiviral therapy.

Management is multidisciplinary:

energy conservation
physiotherapy
occupational therapy
pain management
respiratory assessment
sleep evaluation
nutritional management
assistive devices

Avoid excessive overuse of already compromised motor units.

62. Epidemiology

The most important reservoir is:

Humans

There is no recognized animal reservoir sustaining natural transmission.

This is one reason eradication is theoretically possible.

63. Why eradication is possible

The prerequisites are unusually favorable:

Humans are the major reservoir.
There is no chronic environmental reservoir independent of humans.
Infection produces protective immunity.
Effective vaccines exist.
Surveillance is possible.
The virus is genetically trackable.

64. Current global situation

Wild poliovirus has been reduced by >99% since the launch of the GPEI in 1988. WPV2 and WPV3 have been eradicated; the remaining wild-virus challenge is WPV1. (World Health Organization)

The current major challenge is therefore not simply:

wild polio

but:

wild poliovirus + vaccine-derived poliovirus + containment + surveillance.

65. India

India achieved an extraordinary public-health milestone.

Last wild polio case

13 January 2011

WHO South-East Asia Region certification

27 March 2014

India has subsequently maintained a polio-free status through high vaccination coverage, AFP surveillance and environmental surveillance. (World Health Organization)

This is particularly important for an Indian microbiologist because:

absence of clinical polio ≠ absence of the need for surveillance.

Importation and vaccine-derived poliovirus remain potential threats.

66. National Immunization Schedule — India

The Government of India's current UIP materials list:

OPV

Birth dose
6 weeks
10 weeks
14 weeks
booster at 16–24 months

IPV

The published UIP schedule includes IPV alongside the primary series.

The National Health Mission's current schedule resource remains available and was updated in July 2026. (National Health Mission)

For actual patient vaccination decisions, always use the latest MoHFW/National Immunization Schedule rather than an old textbook table, because programme schedules can change.

67. Why India used both IPV and OPV

This represents a powerful public-health strategy.

IPV

Provides:

individual protection against paralysis

OPV

Provides:

intestinal/mucosal immunity + interruption of transmission

Thus:

IPV protects the individual; OPV is particularly powerful for interrupting community transmission.

The exact programme combination is determined by national policy and current eradication strategy.

68. Polio eradication endgame

The endgame is much more complicated than simply vaccinating children.

It requires:

1. High population immunity

2. AFP surveillance

3. Environmental surveillance

4. Rapid outbreak response

5. Molecular epidemiology

6. VDPV surveillance

7. Immunodeficiency-associated surveillance

8. Laboratory containment

9. Vaccine optimization

10. International coordination

WHO's current strategy emphasizes all of these components. (World Health Organization)

69. Wild vs vaccine-derived poliovirus

Feature	Wild poliovirus	Vaccine-derived poliovirus
Origin	Naturally circulating	Derived from attenuated OPV strain
Vaccine connection	None	Yes
Can cause paralysis	Yes	Yes
Can circulate	Yes	Yes
Main current wild type	WPV1	—
Major VDPV problem	—	cVDPV2
Prevention	Vaccination	High population immunity + appropriate vaccine strategy
Molecular surveillance	Essential	Essential

70. Wild type 2 vs vaccine-derived type 2

This distinction is extremely important.

Wild poliovirus type 2 is eradicated.

Therefore:

Detection of a type-2 poliovirus today requires careful molecular characterization.

It could represent:

vaccine-related virus
cVDPV2
iVDPV2
aVDPV
laboratory-associated material
rarely another classification depending on context

This is why ITD + sequencing is so important.

71. Important exam comparison

Poliovirus vs Coxsackievirus

Both:

Picornaviridae
Enteroviruses
non-enveloped
+ssRNA
acid stable
fecal-oral transmission

But poliovirus has its characteristic:

anterior horn cell tropism → paralytic disease

72. Poliovirus vs rabies

Feature	Poliovirus	Rabies
Family	Picornaviridae	Rhabdoviridae
Genome	+ssRNA	−ssRNA
Envelope	No	Yes
Transmission	Feco-oral	Animal bite/saliva
Main target	Motor neurons	CNS neurons
Paralysis	Flaccid	Usually encephalitic/focal; can be paralytic
Vaccine	IPV/OPV	Inactivated rabies vaccine

73. Poliovirus vs GBS

Poliomyelitis

asymmetric
anterior horn cell
fever often precedes weakness
CSF may show pleocytosis
virus detectable in stool
sensory function generally preserved

GBS

typically symmetric
peripheral demyelinating/axonal neuropathy
albuminocytologic dissociation
no virus required
areflexia prominent

74. High-yield molecular biology pearls

Pearl 1

Poliovirus genome is infectious RNA.

Because it is positive-sense RNA, purified genomic RNA can function as mRNA.

Pearl 2

No 5′ cap

Instead:

VPg

Pearl 3

Translation:

IRES-dependent

Pearl 4

Replication:

3Dpol

Pearl 5

Primer:

VPg

Pearl 6

Host translation shutoff:

2A protease → eIF4G cleavage

Pearl 7

Major capsid antigen:

VP1

Pearl 8

Receptor:

CD155/PVR

Pearl 9

Main diagnostic specimen:

Stool

Pearl 10

Modern molecular epidemiology:

VP1 sequencing

75. High-yield clinical pearls

Pearl 1

Most infections are asymptomatic.

Pearl 2

Paralytic disease is uncommon.

Pearl 3

Paralysis is:

acute + flaccid + asymmetric

Pearl 4

Sensation is usually preserved.

Pearl 5

Main lesion:

anterior horn cells

Pearl 6

Bulbar disease can cause respiratory failure.

Pearl 7

Negative CSF PCR does not exclude polio.

Pearl 8

Two stool specimens are preferred for suspected cases.

Pearl 9

AFP surveillance is central to eradication.

Pearl 10

Environmental surveillance detects silent transmission.

76. High-yield vaccine pearls

IPV

Killed → injection → no VAPP → no cVDPV

OPV

Live attenuated → oral → intestinal replication → excellent mucosal immunity → rare VAPP/cVDPV risk

nOPV2

Live oral vaccine engineered for greater genetic stability → primarily used for type-2 outbreak response.

77. The entire organism in one diagram

                 POLIOVIRUS
                     │
         ┌───────────┴───────────┐
         │                       │
   Picornaviridae           Enterovirus C
         │
   Non-enveloped
         │
   Icosahedral capsid
         │
      +ssRNA
         │
   ┌─────┴───────────┐
   │                 │
 VPg-5′            poly(A)-3′
   │
   IRES
   │
   P1 ───────── P2 ───────── P3
   │             │             │
VP4/VP2/VP3/VP1  replication   3C, 3Dpol
   │
   ↓
CD155 receptor
   ↓
Oropharynx
   ↓
Intestine
   ↓
Lymphoid tissue
   ↓
Viremia
   ↓
CNS in minority
   ↓
Anterior horn cells
   ↓
LMN destruction
   ↓
ASYMMETRIC FLACCID PARALYSIS

78. The diagnostic algorithm a microbiologist should remember

SUSPECTED AFP
      ↓
Immediate notification / investigation
      ↓
Collect 2 stool specimens
24 h apart
      ↓
Transport under appropriate conditions
      ↓
Polio laboratory
      ↓
Virus isolation
      ↓
Poliovirus identification
      ↓
Intratypic differentiation
      ↓
       ┌──────────────┐
       │              │
   Wild/Sabin-like   VDPV concern
       │              │
       └──────┬───────┘
              ↓
       Genome sequencing
              ↓
      Molecular epidemiology
              ↓
      Transmission linkage
              ↓
      Public-health response

CDC specifically emphasizes culture, intratypic differentiation and genome sequencing in the laboratory investigation of suspected poliovirus infection. (CDC)

79. What a physician should remember at the bedside

If you encounter:

A child with acute asymmetric flaccid weakness, reduced reflexes and preserved sensation

do not simply label it "GBS."

Think:

POLIO UNTIL EXCLUDED

Especially if there is:

incomplete vaccination
epidemiological exposure
travel/importation risk
community outbreak
environmental detection
preceding febrile illness

Immediately involve the appropriate public-health authorities and microbiology laboratory.

80. What a microbiologist should remember

The most important principle is:

Polio diagnosis is not merely "detect poliovirus."

The laboratory must answer:

1. Is poliovirus present?

2. Which serotype?

3. Is it wild or vaccine-related?

4. Is it Sabin-like or genetically divergent?

5. Is it circulating?

6. Is there genetic linkage to another case/environmental isolate?

7. Where did the virus likely originate?

8. Is the isolate epidemiologically significant?

That is why modern poliovirus microbiology is fundamentally:

culture + molecular differentiation + sequencing + epidemiology.

81. Ultimate examination answer framework

If asked:

"Poliovirus — morphology, antigenic properties, pathogenesis and laboratory diagnosis"

Use this order:

1. Introduction

2. Classification

3. Morphology

4. Physicochemical properties

5. Genome

6. Viral proteins

7. Antigenic properties

8. Replication

9. Pathogenesis

10. Clinical manifestations

11. Immunity

12. Laboratory diagnosis

specimen
transport
isolation
cell culture
CPE
identification
RT-PCR
ITD
sequencing
serology

13. Differential diagnosis

14. Vaccines

IPV
OPV
VAPP
cVDPV
nOPV2

15. Prevention and control

16. AFP surveillance

17. Environmental surveillance

18. Eradication and containment

19. Conclusion

That structure can comfortably produce a 20–30 mark MD Microbiology answer while also being clinically useful.

Standard sources to study alongside this

For postgraduate microbiology, I would use the following hierarchy:

Murray – Medical Microbiology
Jawetz, Melnick & Adelberg's Medical Microbiology
Koneman's Color Atlas and Textbook of Diagnostic Microbiology
Fields Virology
Fenner and White's Medical Virology
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
WHO Global Polio Eradication Initiative / Global Polio Laboratory Network documents
CDC Pink Book and CDC Poliovirus Laboratory guidance
WHO surveillance and containment manuals
Current Indian National Immunization Schedule / MoHFW-NHM guidance

The WHO/CDC material is particularly important because textbooks cannot keep pace with changes in VDPV classification, nOPV2, eradication strategy, surveillance algorithms and containment policy. WHO's current strategy has already been extended through 2029 for key eradication objectives. (World Health Organization)

One-line memory map

POLIO = Picornavirus → +ssRNA → VPg → IRES → P1/P2/P3 → CD155 → gut replication → viremia → anterior horn cell destruction → asymmetric flaccid paralysis → stool diagnosis → ITD + VP1 sequencing → IPV/OPV → AFP + environmental surveillance → eradication/containment.